Safety and Immunogenicity of a Novel Staphylococcus Aureus Vaccine: Results From the First Study of the Vaccine Dose Range in Humans

Clinical and Vaccine Immunology - United States
doi 10.1128/cvi.00356-10
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Immunogenicity and Safety of a NeuGcGM3 Based Cancer Vaccine: Results From a Controlled Study in Metastatic Breast Cancer Patients.

Human Vaccines
2010English

On the Administration and Dose of Staphylococcus Vaccine

BMJ
1908English

Would Hemodialysis Patients Benefit From a Staphylococcus Aureus Vaccine?

Kidney International
Nephrology
2019English

Safety and Immunogenicity of a Live Attenuated Mumps Vaccine

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2014English

Safety and Immunogenicity of a mRNA-based Chikungunya Vaccine in a Phase 1 Dose-Ranging Trial

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2019English

Safety and Immunogenicity of the DTP/HB /Hib Combination Vaccine: Phase I Study

Paediatrica Indonesiana
2013English

An Escalating Dose Study to Assess the Safety, Tolerability and Immunogenicity of a Herpes Simplex Virus DNA Vaccine, COR-1

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2016English

Comparative Randomized Study of Tolerability, Reactogenicity, Immunogenicity and Safety of the Vaccine «BiVac Polio» (Oral Poliovirus Vaccine Type 1,3)

Epidemiology and Vaccine Prevention
2017English

Safety and Immunogenicity of Hepatitis B Vaccine: A Study on Iranian Navy Personnel

Vaccine Research
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy